This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Max Harman
Research Associate - Molecular Pharmacology at Bicycle Therapeutics
Speaker

Profile

Following studies of Biochemistry at the University of Bath, Max was employed at BicycleTx Ltd where he has worked now for over four years. Max operates as a laboratory scientist within the BicycleTx Molecular Pharmacology group on projects through discovery to preclinical phases. His projects currently are focused on the antiviral, oncology and immuno-oncology areas. With a drive for innovation, he is named inventor on several patents under the Bicycle umbrella.”

Agenda Sessions

  • Bicycles, A Flexible Antiviral Modality with Therapeutic and Prophylactic Relevance In Vivo

    10:30